Here we go.
The New York Times reports that Manny Ramirez and David Ortiz were on that infamous 2003 doping list:
Manny Ramirez and David Ortiz, the
sluggers who propelled the Boston Red Sox to end an 86-year World
Series championship drought and to capture another title three years
later, were among the roughly 100 Major League Baseball players to test
positive for performance-enhancing drugs in 2003, according to lawyers
with knowledge of the results.
Of course, these results were supposed to remain anonymous, but many
high-profile names, including Alex Rodriguez, have managed to slip
Ortiz was asked about the story before Thursday’s game, saying:
“I’m not talking about that anymore. I have no comment.”
It looks like Papi’s lowly .224/.311/.409 line and general deterioration now has an obvious, and rather sad explanation.
Clayton Kershaw had nothing left to prove when he exited the mound during his last Cactus League start on Friday. He finished camp with a 0.00 ERA, made all the more impressive after he extended his scoreless streak to 21 1/3 innings following 6 2/3 frames of one-hit ball against the Royals.
In six spring training starts this year, the Dodgers southpaw racked up 12 hits, four walks and 23 strikeouts. His velocity appeared to fluctuate between the high-80s and low-90s from start to start, but manager Dave Roberts told reporters that he expects Kershaw to get back up to the 93 m.p.h. range next week. Kershaw is tabbed for his eighth consecutive Opening Day start on Thursday.
The 30-year-old lefty is poised to enter his 11th season with the club in 2018. He went 18-4 in 27 starts last year and turned in a 2.31 ERA, 1.5 BB/9 and 10.4 SO/9 over 175 innings. He suffered his fair share of bumps and bruises along the way, including a lower back strain that required a five-week stay on the disabled list.
The Dodgers will open their season against the Giants on Thursday, March 29 at 7:08 PM ET. Given the sudden rash of injuries that hit the Giants’ rotation earlier today, Kershaw’s Opening Day opponent has not yet been announced.